Urothelium Antibodies

Santa Cruz Biotechnology features a diverse variety of Urothelium Antibodies for studying urothelial cells and their functions. Urothelium Antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Urothelial cells line the urinary bladder and play a critical role in maintaining the barrier function of the urinary tract, protecting underlying tissues from toxic substances in urine. Ongoing research focuses on understanding signaling pathways that regulate bladder function and contribute to the pathophysiology of various urological diseases, including bladder cancer and urinary tract infections. Understanding the biology of urothelial cells is essential for developing targeted therapies and improving patient outcomes. Research applications include investigating cell signaling mechanisms, protein expression patterns, and cellular responses to various stimuli. Examining molecular markers helps identify potential therapeutic targets and diagnostic indicators. Current studies explore the role of urothelial cells in maintaining tissue homeostasis and their involvement in disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of urothelial cell biology and developing new therapeutic strategies.